产品名称：Human LIV-1 / SLC39A6 Antibody (LadiratuzumAb, Research Use)
产品编号：NBR-0793
针对靶点：LIV-1 / SLC39A6
抗体药商品名：LadiratuzumAb
抗体药描述：Ladiratuzumab vedotin (LV) is an investigational anti-LIV-1 antibody-drug conjugate with a protease-cleavable linker conjugated to monomethyl auristatin E (MMAE). LV 2.5 mg/kg given every 3 weeks (q3w) was generally well tolerated and has demonstrated encouraging efficacy in patients with pre-treated metastatic triple-negative breast cancer (mTNBC). 产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

  Gene Name:  SLC39A6
Synonyms: LIV-1
Target Description: May act as a zinc-influx transporter.
Ensembl:  ENSG00000141424
Uniprot:  Q13433